Jiangsu Apon Medical Technology Co., Ltd.
SZSE:300753.SZ
16.55 (CNY) • At close October 26, 2023
Overview | Financials
Numbers are in millions (except for per share data and ratios) CNY.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets: | |||||||||||
| Current Assets: | |||||||||||
| Cash & Cash Equivalents
| 201.635 | 200.896 | 249.252 | 274.663 | 388.558 | 420.591 | 436.14 | 169.82 | 141.719 | 74.079 | 12.165 |
| Short Term Investments
| 1 | 1 | -22.718 | -7.633 | -1.453 | -0.929 | -1.483 | -1.858 | -0.965 | 0 | 0 |
| Cash and Short Term Investments
| 202.635 | 201.896 | 249.252 | 274.663 | 388.558 | 420.591 | 436.14 | 169.82 | 141.719 | 74.079 | 12.165 |
| Net Receivables
| 166.827 | 167.669 | 122.476 | 132.52 | 85.698 | 0 | 47.567 | 38.192 | 32.718 | 34.246 | 24.84 |
| Inventory
| 62.709 | 55.688 | 61.04 | 67.421 | 31.73 | 27.866 | 25.391 | 24.333 | 20.859 | 13.17 | 13.355 |
| Other Current Assets
| 26.265 | 18.915 | 12.615 | 17.988 | 16.96 | 3.757 | 8.787 | 4.438 | 5.834 | 7.937 | 31.09 |
| Total Current Assets
| 458.437 | 442.303 | 445.383 | 484.207 | 523.296 | 539.475 | 517.885 | 234.443 | 201.13 | 128.034 | 81.45 |
| Non-Current Assets: | |||||||||||
| Property, Plant & Equipment, Net
| 202.829 | 212.819 | 206.983 | 212.763 | 168.589 | 143.726 | 99.211 | 38.116 | 39.153 | 31.46 | 31.716 |
| Goodwill
| 54.706 | 53.241 | 53.241 | 69.406 | 33.887 | 16.498 | 16.498 | 16.498 | 16.498 | 0 | 0 |
| Intangible Assets
| 36.305 | 34.025 | 35.575 | 33.243 | 37.673 | 43.045 | 32.485 | 37.523 | 32.486 | 2.047 | 2.103 |
| Goodwill and Intangible Assets
| 91.011 | 87.267 | 88.817 | 102.649 | 71.56 | 59.543 | 48.983 | 54.021 | 48.984 | 2.047 | 2.103 |
| Long Term Investments
| 80.194 | 75.54 | 103.844 | 87.016 | 60.453 | 7.842 | 2.504 | 3.429 | 2.834 | 0.484 | 0 |
| Tax Assets
| 16.823 | 22.79 | 24.406 | 8.731 | 2.12 | 3.184 | 3.122 | 2.388 | 2.289 | 2.258 | 0.06 |
| Other Non-Current Assets
| 14.192 | 18.854 | 0.781 | 3.693 | 1.222 | 3.873 | 16.251 | 0.858 | 0.117 | 16 | 0.474 |
| Total Non-Current Assets
| 405.048 | 417.27 | 424.831 | 414.852 | 303.944 | 218.167 | 170.071 | 98.812 | 93.377 | 52.249 | 34.353 |
| Total Assets
| 863.485 | 859.573 | 870.213 | 899.058 | 827.239 | 757.642 | 687.955 | 333.255 | 294.507 | 180.283 | 115.804 |
| Liabilities & Equity: | |||||||||||
| Current Liabilities: | |||||||||||
| Account Payables
| 21.817 | 29.916 | 46.926 | 27.763 | 31.417 | 30.449 | 29.081 | 4.683 | 4.338 | 2.333 | 5.944 |
| Short Term Debt
| 48.445 | 39.238 | 29.433 | 0 | 0 | 0 | 0 | 0 | 0 | 3 | 3 |
| Tax Payables
| 8.205 | 2.097 | 6.61 | 8.492 | 14.487 | 14.329 | 5.872 | 8.868 | 10.847 | 10.201 | 8.851 |
| Deferred Revenue
| 0 | 0 | 64.701 | 4.502 | 3.383 | 5.235 | 7.644 | 5.003 | 6.563 | 23.994 | 19.836 |
| Other Current Liabilities
| 47.154 | 58.622 | 33.444 | 35.801 | 39.335 | 35.49 | 36.985 | 39.6 | 49.734 | 19.347 | 16.634 |
| Total Current Liabilities
| 125.62 | 129.873 | 147.118 | 76.557 | 85.238 | 80.268 | 71.938 | 53.15 | 64.92 | 34.882 | 34.429 |
| Non-Current Liabilities: | |||||||||||
| Long Term Debt
| 28.271 | 30.658 | 34.53 | 39.856 | 3.727 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue Non-Current
| 1.704 | 0 | 1.904 | 1.989 | 2 | 2 | 2.46 | 0.72 | 0 | 0 | 0 |
| Deferred Tax Liabilities Non-Current
| 0.027 | 0.042 | 0.299 | 0.135 | 0.161 | 0.492 | 0.162 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities
| 0 | 1.804 | 0 | 0 | -1.727 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Non-Current Liabilities
| 30.002 | 32.504 | 36.733 | 41.98 | 2.161 | 2.492 | 2.622 | 0.72 | 0 | 0 | 0 |
| Total Liabilities
| 155.622 | 162.377 | 183.851 | 118.538 | 87.399 | 82.761 | 74.56 | 53.871 | 64.92 | 34.882 | 34.429 |
| Equity: | |||||||||||
| Preferred Stock
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Common Stock
| 126.048 | 126.048 | 126.048 | 126.048 | 105.04 | 80.8 | 80.8 | 60.6 | 60.6 | 28.627 | 26.685 |
| Retained Earnings
| 190.033 | 196.968 | 188.103 | 264.481 | 247.082 | 191.378 | 132.641 | 68.681 | 26.35 | 55.76 | 37.084 |
| Accumulated Other Comprehensive Income/Loss
| 0 | 0 | 41.523 | 41.523 | 36.482 | 27.55 | 16.263 | 10.134 | 4.543 | 31.279 | -0 |
| Other Total Stockholders Equity
| 383.578 | 373.187 | 329.905 | 347.566 | 387.395 | 402.703 | 391.417 | 132.423 | 132.423 | 56.627 | 13.701 |
| Total Shareholders Equity
| 699.659 | 696.203 | 685.58 | 779.618 | 739.52 | 674.881 | 604.858 | 271.838 | 223.917 | 141.013 | 77.47 |
| Total Equity
| 707.863 | 697.196 | 686.362 | 780.521 | 739.84 | 674.881 | 613.395 | 279.385 | 229.586 | 145.401 | 81.375 |
| Total Liabilities & Shareholders Equity
| 863.485 | 859.573 | 870.213 | 899.058 | 827.239 | 757.642 | 687.955 | 333.255 | 294.507 | 180.283 | 115.804 |